Nav: Home

Stenting of narrow pulmonary artery benefits patients with congenital heart disease

March 14, 2016

WASHINGTON (March 14, 2016) -- The use of a stent to repair pulmonary artery stenosis in children and adults with congenital heart disease was successful in the majority of patients, but many also experienced serious complications, according to a study published today in the Journal of the American College of Cardiology.

Pulmonary artery stenosis occurs when the pulmonary artery, a large blood vessel that connects the heart to the lungs, is significantly narrowed or small, usually as a result of a congenital defect. This condition causes the heart's right ventricle to work harder to pump blood into the artery, leading to significant health problems.

Using data from the American College of Cardiology IMPACT Registry, researchers examined records from 1,183 patients treated at 59 U.S. hospitals between January 2011 and January 2014. The age of the population ranged from less than a year to older than 18, with the average age about 9 years old. Of that group, 262 patients had a single ventricle.

For patients with two ventricles, researchers developed two definitions to measure success, each with separate benchmarks. Both definitions looked at whether pressure in the right ventricle decreased and the diameter of the pulmonary artery increased following the procedure. The second definition included an additional measurement--whether the pressure across the obstructed vessel changed, and by how much.

Researchers found that when using the first definition, 76 percent of the procedures were considered successful, while 86 percent based on the second definition were deemed a success. The overall success rate was more than 75 percent.

For single ventricle patients, researchers used one definition to measure success: an increase in the diameter of the pulmonary artery after stenting. Among those procedures, 75 percent were considered successful. The complication rate for all patients in the study cohort was 14 percent, with 9 percent experiencing death or a major adverse event, often associated with bleeding.

After further analysis, researchers found that patients with stenosis near the artery's origin had a higher probability of a successful outcome. Patients with a single ventricle were 2.3 times more likely to have a major adverse event than those with two ventricles. In addition, patients with low body weight or undergoing stenting as an emergency procedure had a higher risk of death or a major adverse event.

Matthew J. Lewis, M.D., M.P.H., the study's lead author and a cardiology fellow at Columbia University Medical Center, said that "these findings should inform referring physicians and operators regarding patient selection prior to pulmonary artery stenting." He added that given the high rate of adverse events, further study is needed to determine how to minimize patient risk and further validate definitions of procedural success.

In an accompanying editorial, Phillip Moore, M.D., M.B.A., director of the Pediatric Cardiac Catheterization Laboratory at the University of California San Francisco, pointed out that "the success rate is lower and the complication rate higher for this procedure than previously recognized," and that a single ventricle has, for the first time, been shown to be associated with higher risk. He attributed both findings to the power of big data, which allowed for a more well-defined analysis of predictors of both success and risk.

Noting that the two definitions of success resulted in statistically significant different rates that could affect conclusions drawn from the findings, he said that there is a need for a clear, widely agreed upon definition of procedural success. Similarly, the definitions of major and minor adverse events must be clinically relevant and accepted to allow for accurate measurements and comparisons.

Nonetheless, Moore "applauds the authors for an excellent analysis of the largest dataset available on pulmonary artery stent implantation." He encourages the congenital interventional community to engage in a robust discussion on specific definitions of procedural success so that "we can begin to reap the true potential benefits of our 'big data' efforts."
-end-
The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.

The Journal of the American College of Cardiology, which publishes peer-reviewed research on all aspects of cardiovascular disease, is the most widely read cardiovascular journal worldwide. JACC is ranked No. 1 among cardiovascular journals worldwide for its scientific impact.

American College of Cardiology

Related Congenital Heart Disease Articles:

Genes responsible for severe congenital heart disease identified by Pitt researcher
Genes responsible for hypoplastic left heart syndrome identified using mouse models.
Ablation for atrial fibrillation proven safe and effective for patients with congenital heart disease, Penn study finds
In a new study presented today at the Heart Rhythm Society's 38th Annual Scientific Session in Chicago, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that CHD patients -- even with complex defects -- can safely undergo ablation for AF, with similar success rates as patients with normal hearts.
Lessening radiation risk for children with congenital and acquired heart disease
Newly released recommendations for pediatric radiation safety will be discussed during the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans.
High-throughput, in vivo validation of candidate congenital heart disease genes
Specific genetic errors that trigger congenital heart disease in humans can be reproduced reliably in Drosophila melanogaster -- the common fruit fly -- an initial step toward personalized therapies for patients in the future.
Women with high-risk congenital heart disease can have successful pregnancies
Women with high-risk congenital heart disease can have successful pregnancies but should seek counseling before conception to understand how their conditions could affect pregnancy and their child's health.
First US babies treated in study of adult stem cell therapy for congenital heart disease
In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine (UM SOM) and the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have begun testing to see whether adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS).
Children dying preventable deaths from congenital heart disease
Over one million children are born with congenital heart disease (CHD) each year, and 90 percent are born in poor regions with little or no access to care.
Einstein scientist receives $7.5 million grant for congenital heart disease research
The National Institutes of Health has awarded Bernice Morrow, Ph.D., at Albert Einstein College of Medicine and collaborators at the Children's Hospital of Philadelphia a five-year, $7.5 million grant to study the genetics of congenital heart abnormalities.
Mother's blood sugar measurement associated with baby's congenital heart disease risk
For the first time, researchers have shown that the level of blood sugar measured in the first trimester of pregnancy may be associated with the risk of delivering a baby with congenital heart disease, according to a preliminary study presented at the American Heart Association's Scientific Sessions 2016.
Women with congenital heart disease have better shot at healthy pregnancies
New research from the Perelman School of Medicine at the University of Pennsylvania reveals that women with CHD who are deemed high risk by conventional measures are more likely to have safe, healthy pregnancies than current risk-assessments suggest.

Related Congenital Heart Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...